ADVANCED/METASTATIC BREAST CANCER
Clinical trials for ADVANCED/METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of drugs aims to keep HER2+ breast cancer in check
Disease control Recruiting nowThis Phase 2 trial is testing whether adding the drug dalpiciclib to standard anti-HER2 and hormone therapy can help keep advanced breast cancer from growing. It involves 57 women with HR+/HER2+ metastatic breast cancer whose disease has not worsened after initial treatment. The …
Matched conditions: ADVANCED/METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for late-stage breast cancer patients with no other options
Disease control Recruiting nowThis study tests whether a new treatment called Bria-IMT, given with an immunotherapy drug, helps people with advanced metastatic breast cancer live longer compared to standard chemotherapy. About 404 adults whose cancer has not responded to other treatments will participate. The…
Matched conditions: ADVANCED/METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: BriaCell Therapeutics Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Blood test study aims to unlock secrets of Hard-to-Treat breast cancer
Knowledge-focused Recruiting nowThis pilot study is looking at genetic material from tumors (circulating tumor DNA) found in the blood of 30 people with advanced or metastatic HER2-low breast cancer. The goal is to identify specific mutations in these cancers. This is an observational study, meaning no new trea…
Matched conditions: ADVANCED/METASTATIC BREAST CANCER
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
13,500 breast cancer patients join quest for better treatment predictors
Knowledge-focused Recruiting nowThis study is collecting blood and tumor samples from 13,500 breast cancer patients, both early-stage and advanced/metastatic. The goal is to discover biomarkers that can predict how well a treatment will work and to improve overall healthcare quality. Researchers will analyze ge…
Matched conditions: ADVANCED/METASTATIC BREAST CANCER
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC